Exploratory Evaluation of Staff-Mediated Doll Therapy in Chinese Residential Dementia Care: A Mixed-Methods Cluster Randomized Pilot Trial
1 other identifier
interventional
142
1 country
1
Brief Summary
This study is a two-phase explanatory sequential mixed-methods study in Chinese residential dementia care. Phase I is a pragmatic 1:1 exploratory pilot cluster randomized trial in six nursing homes in Zhengzhou, China, comparing staff-mediated doll therapy plus routine nursing care with routine nursing care alone among 142 residents with dementia assessed at baseline, 6 weeks, and 12 weeks. Registered primary outcomes are class-specific daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants. Secondary and contextual outcomes include behavioral and psychological symptoms of dementia, activities of daily living, cognitive enhancer use, traditional Chinese medicine use, and doll engagement/adherence. Phase II uses semi-structured interviews with staff and family caregivers to explore acceptability, implementation, training needs, cultural fit, and ethical considerations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedStudy Start
First participant enrolled
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 13, 2026
July 1, 2026
1.4 years
July 11, 2024
July 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Class-Specific Daily Medication Dose
This primary outcome assesses class-specific mean daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants over 12 weeks. Antipsychotics are expressed as chlorpromazine-equivalent daily dose, anxiolytics as diazepam-equivalent daily dose, and antidepressants using the WHO defined daily dose framework. Changes are compared between doll therapy plus routine nursing care and routine care alone.
12 weeks
Secondary Outcomes (2)
Change in Behavioral and Psychological Symptoms of Dementia (BPSD)
12 weeks
Change in Activities of Daily Living (ADL)
12 weeks
Other Outcomes (3)
Change in Cognitive Enhancer Use
12 weeks
Change in Traditional Chinese Medicine Use
12 weeks
Doll Engagement and Adherence
12 weeks
Study Arms (2)
Staff-Mediated Doll Therapy plus Routine Nursing Care
EXPERIMENTALResidents in intervention homes received routine nursing care plus a staff-mediated doll-therapy care package. The package included staff training, a structured doll-therapy introduction with eight planned sessions over approximately 15 days, continued access to a personal doll during routine care, structured interaction and relational engagement, and ongoing monitoring of resident assent, dissent, distress, and fit.
Routine Nursing Care
NO INTERVENTIONResidents in control homes received routine nursing care alone. Control homes did not receive study-provided dolls or structured doll-therapy training during the study period.
Interventions
Staff-mediated doll therapy is a person-centered, attachment-informed non-pharmacological care package in which trained nursing-home staff introduce a lifelike doll respectfully, support resident-led interaction, monitor assent and dissent, and provide continued access to a personal doll during routine care. The intervention included eight planned introductory sessions over approximately 15 days, structured interaction, relational engagement, and implementation within ordinary nursing-home care.
Eligibility Criteria
You may qualify if:
- Age 65 years or older.
- Nursing home resident with a documented clinical diagnosis of dementia recorded in the medical or nursing-home record by a qualified physician using DSM-5, ICD-10, ICD-11, or current Chinese clinical guidelines for dementia and cognitive impairment; where the underlying diagnostic criteria were not specified in the record, the site clinician reconfirmed the diagnosis against DSM-5 criteria before enrollment.
- Adequate visual capacity to recognize a doll at screening.
- Sufficient upper-limb function to hold or caress the doll safely.
- Availability of a legally authorized representative able to provide written informed consent.
- Resident assent whenever appropriate.
You may not qualify if:
- Acute medical instability.
- Severe sensory or physical limitations preventing safe participation.
- Severe communication impairment precluding meaningful participation.
- Major psychiatric disorders unrelated to dementia.
- Resident dissent or refusal when assent was appropriate, or safety concerns that made doll interaction unsuitable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sias University
Zhengzhou, Henan, 451100, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhenti Cui
Social and Preventive Medicine, Malaya University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The intervention was visible in routine care, so residents, direct caregivers, and intervention deliverers were not blinded. Medication outcomes were extracted from medication records by assessors masked to allocation where feasible; caregiver-reported NPI-12 and Barthel ratings could not be fully blinded.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Candidate
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 17, 2024
Study Start
July 31, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
July 13, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- 3 months to 5 years following article publication
- Access Criteria
- Researchers must provide a methodologically sound proposal and obtain appropriate ethics and institutional approvals where required. Access will be subject to review by the study team and the responsible institution, and requestors must sign a data access agreement covering confidentiality, permitted use, and secure storage.
De-identified quantitative analysis-ready data underlying the reported results and analytic code may be shared with qualified researchers on reasonable request. Because the dataset contains potentially identifiable nursing-home clinical information, data will not be posted publicly. The qualitative coding framework may also be available on reasonable request.